DE69703915T2 - Benzimidazol-, Benzoxazol- und Benzothiazolderivate, welche als Inhibitoren des Interleukin 1beta verwendbar sind - Google Patents

Benzimidazol-, Benzoxazol- und Benzothiazolderivate, welche als Inhibitoren des Interleukin 1beta verwendbar sind

Info

Publication number
DE69703915T2
DE69703915T2 DE69703915T DE69703915T DE69703915T2 DE 69703915 T2 DE69703915 T2 DE 69703915T2 DE 69703915 T DE69703915 T DE 69703915T DE 69703915 T DE69703915 T DE 69703915T DE 69703915 T2 DE69703915 T2 DE 69703915T2
Authority
DE
Germany
Prior art keywords
optionally substituted
aryl
benzoxazole
benzimidazole
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69703915T
Other languages
English (en)
Other versions
DE69703915D1 (de
Inventor
Nanteuil Guillaume De
Bernard Portevin
Jacqueline Bonnet
Armel Fradin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of DE69703915D1 publication Critical patent/DE69703915D1/de
Application granted granted Critical
Publication of DE69703915T2 publication Critical patent/DE69703915T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
DE69703915T 1996-07-26 1997-07-24 Benzimidazol-, Benzoxazol- und Benzothiazolderivate, welche als Inhibitoren des Interleukin 1beta verwendbar sind Expired - Fee Related DE69703915T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9609416A FR2751649B1 (fr) 1996-07-26 1996-07-26 Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
DE69703915D1 DE69703915D1 (de) 2001-02-22
DE69703915T2 true DE69703915T2 (de) 2001-08-02

Family

ID=9494506

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69703915T Expired - Fee Related DE69703915T2 (de) 1996-07-26 1997-07-24 Benzimidazol-, Benzoxazol- und Benzothiazolderivate, welche als Inhibitoren des Interleukin 1beta verwendbar sind

Country Status (19)

Country Link
US (1) US5972968A (de)
EP (1) EP0820990B1 (de)
JP (1) JPH1067753A (de)
CN (1) CN1090620C (de)
AT (1) ATE198744T1 (de)
AU (1) AU715751B2 (de)
BR (1) BR9704076A (de)
CA (1) CA2211444C (de)
DE (1) DE69703915T2 (de)
DK (1) DK0820990T3 (de)
ES (1) ES2155660T3 (de)
FR (1) FR2751649B1 (de)
GR (1) GR3035434T3 (de)
HU (1) HUP9701297A1 (de)
NO (1) NO308602B1 (de)
NZ (1) NZ328431A (de)
PL (1) PL321336A1 (de)
PT (1) PT820990E (de)
ZA (1) ZA976655B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602029D0 (en) * 1996-02-01 1996-04-03 Fujisawa Pharmaceutical Co New heterocyclic compounds
FR2766822B1 (fr) * 1997-07-30 2001-02-23 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6248770B1 (en) * 1998-07-09 2001-06-19 Boehringer Ingelheim Pharma Kg Benzimidazoles having antithrombotic activity
WO2000024397A1 (fr) * 1998-10-23 2000-05-04 Akira Matsumori Composition de medicament immunomodulateur
US6451832B2 (en) 1999-12-23 2002-09-17 Boehringer Ingelheim Pharma Kg Benzimidazoles with antithrombotic activity
EP1253921A4 (de) 2000-01-28 2004-10-13 Merck & Co Inc Behandlung und prophylaxe des prostatakrebs mit cox-2 selektiven inhibitoren
US6660858B2 (en) 2001-03-28 2003-12-09 Lion Bioscience Ag 2-aminobenzoxazole derivatives and combinatorial libraries thereof
DE602005011844D1 (de) * 2004-11-02 2009-01-29 Pfizer Sulfonylbenzimidazolderivate
PE20070335A1 (es) * 2005-08-30 2007-04-21 Novartis Ag Benzimidazoles sustituidos y metodos para su preparacion
FR2891273B1 (fr) * 2005-09-27 2007-11-23 Aventis Pharma Sa NOUVEAUX DERIVES BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE NOTAMMENT COMME INHIBITEURS DE CMet
CA2747801A1 (en) * 2009-01-22 2010-07-29 Raqualia Pharma Inc. N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
CA2754446A1 (en) 2009-03-05 2010-09-10 Daiichi Sankyo Company, Limited Pyridine derivative
MX2012005248A (es) 2009-11-06 2012-06-14 Univ Vanderbilt Aril- y heteroaril-sulfonas como potenciadores alostericos de mglur4, composiciones y metodos de tratamiento de la disfuncion neurologica.
AR096654A1 (es) 2013-06-20 2016-01-27 Ab Science Derivados de benzimidazol como inhibidores selectivos de proteína quinasa

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2290430A1 (fr) * 1974-11-06 1976-06-04 Aries Robert Nouveau mode de synthese d'esters carbamiques derives du benzimidazole
LU75684A1 (de) * 1976-08-27 1978-04-13
DE3067431D1 (en) * 1979-07-20 1984-05-17 Ciba Geigy Ag Coumarine compounds, processes for their manufacture as well as the intermediate products used perse and their utilisation for the dyeing or printing of textiles
GR78209B (de) * 1982-04-15 1984-09-26 May & Baker Ltd
US4430502A (en) * 1982-08-13 1984-02-07 The Upjohn Company Pyridinyl substituted benzimidazoles and quinoxalines
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
IT1222412B (it) * 1987-07-31 1990-09-05 Chiesi Farma Spa Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono
JP2869561B2 (ja) * 1989-05-22 1999-03-10 大塚製薬株式会社 血小板粘着抑制剤
JPH06759B2 (ja) * 1989-09-22 1994-01-05 ファイザー製薬株式会社 新規なベンゾイミダゾール化合物
IE910278A1 (en) * 1990-02-16 1991-08-28 Ici Plc Heterocyclic compounds
JPH08294229A (ja) * 1995-04-20 1996-11-05 Nec Corp 半導体集積回路装置
JPH09169729A (ja) * 1995-12-19 1997-06-30 Green Cross Corp:The 非ペプチド型インターロイキン８拮抗剤
JP3243733B2 (ja) * 1996-08-07 2002-01-07 雪印乳業株式会社 新規イソキノリン誘導体
JP2007024865A (ja) * 2005-06-17 2007-02-01 Renesas Technology Corp 半導体装置
KR100861371B1 (ko) * 2007-06-25 2008-10-01 주식회사 하이닉스반도체 온도센서 및 이를 이용한 반도체 메모리 장치
JP2009058438A (ja) * 2007-08-31 2009-03-19 Toshiba Corp 温度検出回路
JP5888009B2 (ja) * 2012-03-08 2016-03-16 株式会社豊田中央研究所 温度センサ回路

Also Published As

Publication number Publication date
ES2155660T3 (es) 2001-05-16
HU9701297D0 (en) 1997-09-29
JPH1067753A (ja) 1998-03-10
PT820990E (pt) 2001-06-29
FR2751649B1 (fr) 1998-08-28
EP0820990A2 (de) 1998-01-28
EP0820990B1 (de) 2001-01-17
AU3017297A (en) 1998-02-05
ATE198744T1 (de) 2001-02-15
EP0820990A3 (de) 1998-07-29
DE69703915D1 (de) 2001-02-22
CA2211444A1 (fr) 1998-01-26
BR9704076A (pt) 1999-05-11
CN1174192A (zh) 1998-02-25
HUP9701297A1 (hu) 1999-09-28
CN1090620C (zh) 2002-09-11
NZ328431A (en) 1997-12-19
DK0820990T3 (da) 2001-05-07
AU715751B2 (en) 2000-02-10
US5972968A (en) 1999-10-26
NO973443L (no) 1998-01-27
FR2751649A1 (fr) 1998-01-30
CA2211444C (fr) 2002-07-09
PL321336A1 (en) 1998-02-02
NO308602B1 (no) 2000-10-02
GR3035434T3 (en) 2001-05-31
ZA976655B (en) 1998-02-10
NO973443D0 (no) 1997-07-25

Similar Documents

Publication Publication Date Title
DE69703915D1 (de) Benzimidazol-, Benzoxazol- und Benzothiazolderivate, welche als Inhibitoren des Interleukin 1beta verwendbar sind
ES2059069T3 (es) Nuevos derivados de 1-alcoxi-(2-acilamino-etil)-naftalenos y su procedimiento de preparacion.
ATE214393T1 (de) Bis(3,4-dialkylbenzyliden)sorbitolacetale und diese enthaltende zusammensetzungen
FI893751A (fi) Kemiska foereningar.
DK0409435T3 (da) Heteroarylpiperaziner som antipsykotiske midler
TR25111A (tr) Kontrast ortami
DK37691A (da) Substituerede beta-diketoner, farmaceutiske midler indeholdende disse forbindelser samt anvendelse deraf
DE69603667T2 (de) Indol-, Indazol- und Benzisoxazolderivate zur Behandlung von Schizophrenia
FI892681A0 (fi) Nya jodade icke-joniska trijodbenzenfoereningar och dessa innehaollande kontrastmedel.
DE3689987T2 (de) Desinfektion von Kontaktlinsen.
NO972943D0 (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
PT1120415E (pt) Compostos de isoxazoliltiofeno substituido
FR2796274B1 (fr) Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
FR2566407B1 (fr) Nouveaux derives de l'isoxazoloquinoleine, procede de preparation, application a titre de medicaments, et compositions les renfermant
FI905664A (fi) Glutarsyraderivat och deras framstaellningsfoerfaranden.
NO972942L (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
ATE88614T1 (de) Verwendung eines mittels zum foerdern des tierwachstums.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LES LABORATOIRES SERVIER, NEUILLY SUR SEINE, FR

8339 Ceased/non-payment of the annual fee